Weedon S[au] - Search Results

Year	Number of Results
1998	2
1999	1
2000	1
2013	1
2019	1
2021	1
2022	2

1

Tkachenko E, Blankenship K, Goldberg D, Scharf MJ, Weedon S, Levin NA. Tkachenko E, et al. Among authors: weedon s. J Am Acad Dermatol. 2021 Mar;84(3):e123. doi: 10.1016/j.jaad.2019.06.011. Epub 2019 Jun 13. J Am Acad Dermatol. 2021. PMID: 31307789 No abstract available.

2

Gender-inclusive writing for epidemiological research on pregnancy.

Rioux C, Weedon S, London-Nadeau K, Paré A, Juster RP, Roos LE, Freeman M, Tomfohr-Madsen LM. Rioux C, et al. Among authors: weedon s. J Epidemiol Community Health. 2022 Sep;76(9):823-827. doi: 10.1136/jech-2022-219172. Epub 2022 Jun 28. J Epidemiol Community Health. 2022. PMID: 35764388

3

Sex and gender terminology: a glossary for gender-inclusive epidemiology.

Rioux C, Paré A, London-Nadeau K, Juster RP, Weedon S, Levasseur-Puhach S, Freeman M, Roos LE, Tomfohr-Madsen LM. Rioux C, et al. Among authors: weedon s. J Epidemiol Community Health. 2022 Jun 20:jech-2022-219171. doi: 10.1136/jech-2022-219171. Online ahead of print. J Epidemiol Community Health. 2022. PMID: 35725304

4

Prospective assessment of outcomes following disposable arthroscopy of the temporomandibular joint.

Weedon S, Ahmed N, Sidebottom AJ. Weedon S, et al. Br J Oral Maxillofac Surg. 2013 Oct;51(7):625-9. doi: 10.1016/j.bjoms.2013.06.004. Epub 2013 Jul 22. Br J Oral Maxillofac Surg. 2013. PMID: 23886497

5

Adenoviral delivery of B7-1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells.

Gilligan MG, Knox P, Weedon S, Barton R, Kerr DJ, Searle P, Young LS. Gilligan MG, et al. Among authors: weedon s. Gene Ther. 1998 Jul;5(7):965-74. doi: 10.1038/sj.gt.3300672. Gene Ther. 1998. PMID: 9813668

6

Virus-directed enzyme prodrug therapy using CB1954.

Grove JI, Searle PF, Weedon SJ, Green NK, McNeish IA, Kerr DJ. Grove JI, et al. Among authors: weedon sj. Anticancer Drug Des. 1999 Dec;14(6):461-72. Anticancer Drug Des. 1999. PMID: 10834268 Review.

7

Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductase.

Weedon SJ, Green NK, McNeish IA, Gilligan MG, Mautner V, Wrighton CJ, Mountain A, Young LS, Kerr DJ, Searle PF. Weedon SJ, et al. Int J Cancer. 2000 Jun 15;86(6):848-54. doi: 10.1002/(sici)1097-0215(20000615)86:6<848::aid-ijc14>3.0.co;2-b. Int J Cancer. 2000. PMID: 10842200 Free article.

8

Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. coli nitroreductase gene.

Searle PF, Weedon SJ, McNeish IA, Gilligan MG, Ford MJ, Friedlos F, Springer CJ, Young LS, Kerr DJ. Searle PF, et al. Among authors: weedon sj. Adv Exp Med Biol. 1998;451:107-13. doi: 10.1007/978-1-4615-5357-1_17. Adv Exp Med Biol. 1998. PMID: 10026858 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results